Skip to main content
Precision BioSciences, Inc. (DTIL)
NASDAQ: DTIL · Real-Time Price · USD
4.710
+0.100 (2.17%)
At close: Mar 9, 2026, 4:00 PM EDT
4.555
-0.155 (-3.28%)
After-hours: Mar 9, 2026, 7:58 PM EDT

Precision BioSciences Revenue

Precision BioSciences had revenue of $13.00K in the quarter ending September 30, 2025, a decrease of -97.74%. This brings the company's revenue in the last twelve months to $698.00K, down -99.07% year-over-year. In the year 2024, Precision BioSciences had annual revenue of $68.70M with 40.98% growth.

Revenue (ttm)
$698.00K
Revenue Growth
-99.07%
P/S Ratio
162.43
Revenue / Employee
$10,418
Employees
67
Market Cap
113.38M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202468.70M19.97M40.98%
Dec 31, 202348.73M23.63M94.15%
Dec 31, 202225.10M-90.43M-78.28%
Dec 31, 2021115.53M91.24M375.72%
Dec 31, 202024.29M2.05M9.20%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Agenus 106.83M
Fortress Biotech 62.30M
Codexis 52.93M
Korro Bio 7.37M
Equillium 4.39M
Coya Therapeutics 3.99M
Inovio Pharmaceuticals 182.34K
Genelux 8.00K
Revenue Rankings

DTIL News

More News